2 financial shares to pay dividends in 2017

Challenger Ltd (ASX:CGF) and Mortgage Choice Limited (ASX: MOC) could be two of the best financial stocks next year.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The prospect of rising interest rates is bad news for growth stocks like Class Ltd (ASX: CL1) and REA Group Limited (ASX: REA), as well as defensive stocks like Sydney Airport Holdings Ltd (ASX: SYD) and Westfield Corp Ltd (ASX: WFD).

However, it could be good news for financial stocks that would benefit from a rising interest rate. It may benefit banks like Bank of Queensland Limited (ASX: BOQ) and Bendigo and Adelaide Bank Ltd (ASX: BEN), but big banks like these and others may have their own problems in the coming years.

The two financial companies below could benefit fairly substantially from the interest rate changes without the potential need to issue more shares like the big banks:

Mortgage Choice Limited (ASX: MOC)

Mortgage Choice is one of Australia's largest independent loan brokers with a market capitalisation of $277 million. It earns a vast majority of its income from loan brokerage, but is slowly diversifying its earnings. In FY15, 90.6% of revenue was from brokerage and in FY16 this reduced to 89.5%. Most of the diversification of revenue was from an increase in its financial planning division.

It had a pleasing FY16 as it increased cash earnings per share by 10% and dividends per share by 6.5%.

A big part of what will improve Mortgage Choice's prospects is the usage of brokers for new loans. In March 2014 around 50% of Australian loans were done through a broker, in March 2015 it was 51.9% and in March 2016 it was 53.7%. This is a very pleasing trend for Mortgage Choice shareholders.

But it also requires Mortgage Choice to maintain or grow its market share of the broker market. In the second half of FY15 its market share was 3.6%, in the first half of FY16 it was 3.65% and in the second half of FY16 it was 3.76%, another pleasing trend for shareholders.

Even if interest rates weren't to change, Mortgage Choice is heading in the right direction. However, if interest rates do change there may be a lot of churn from mortgage holders changing to a better loan than the one they are currently in. As Mortgage Choice is receiving more commission from new loans, this could be a sizable boost to profit.

Mortgage Choice is trading with a price/earnings ratio of 14.2 and a grossed up dividend yield of 10.57%.

Challenger Ltd (ASX: CGF)

Challenger is Australia's leading provider of annuities to people seeking reliable income products and it has a market capitalisation of $6.3 billion.

It has large tailwinds as a large number of baby boomers hit retirement age increases and they want to convert their capital into a secure income source. Challenger puts a lot of this money into fixed interest products and the rest into higher growth options like shares and property to hopefully make the capital work harder.

In the second half of FY16 Challenger grew its annuity sales by 45% over the prior corresponding period. This is very impressive growth considering the level of sales Challenger was already achieving.

If the interest rates do rise, Challenger would be able to offer annuities with higher rates of return for the retiree which would make them more attractive and therefore potentially attract more annuity sales.

Challenger is trading at 16.8x FY17's estimated earnings with a grossed up dividend yield of 4.21%.

Foolish takeaway

A large percentage of businesses' share prices may be affected negatively over the next few months due to a re-rating of what investors are willing to pay for 'riskier' assets like shares.

However, there's a good chance that Challenger and Mortgage Choice would be able to increase their revenue and profits from this change which could increase their share prices in the medium term. I think both businesses look like a decent buy at these prices, but by next week they may look cheaper and even more attractive.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of Class Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »